The European Commission (EC) said it had signed a pre-contract with 'AstraZeneca,' a British farmaceutical company, for purchasing 300 million doses of an anti-coronavirus vaccine.
EC said in a statement that the pre-contract applied to all European Union member states and that new hundred million doses would be ordered if proved efficient and safe.
It will donate the vaccines to less developed countries and continues negotiations with other producers of the vaccine, but does not specify.
We've reached a first agreement with the pharmaceutical company@AstraZenecato purchase a potential vaccine against the#coronavirus.— European Commission (@EU_Commission)August 14, 2020
Our talks with several other manufacturers continue in order to bring more candidates into the EU vaccines portfolio.#StrongerTogether
The British vaccine is currently going through the second and third broad clinical trials for safety and its immunogenicity.
Russia's President Vladimir Putinsaid on Tuesday his country had produced the vaccine and that it would soon be administrated.
However, the announcement caused some concerns in the West, with scientists worldwide saying that the headlong rush could backfire.